Hypothesis

3 Matching Annotations

May 2024
aacrjournals.org aacrjournals.org

Xevinapant combined with pembrolizumab in patients with advanced, pretreated colorectal and pancreatic cancer: results of the phase 1b/2 CATRIPCA trial

3
1. scibot 23 May 2024
  
  in Public
  
  RRID:SCR_002798
  
  DOI: 10.1158/1078-0432.CCR-23-2893
  
  Resource: GraphPad Prism (RRID:SCR_002798)
  
  Curator: @abever99
  
  SciCrunch record: RRID:SCR_002798
  
  What is this?
  
  DOI:10.1158/1078-0432.CCR-23-2893 RRID:SCR_002798
2. scibot 23 May 2024
  
  in Public
  
  RRID:SCR_008520
  
  DOI: 10.1158/1078-0432.CCR-23-2893
  
  Resource: FlowJo (RRID:SCR_008520)
  
  Curator: @abever99
  
  SciCrunch record: RRID:SCR_008520
  
  What is this?
  
  RRID:SCR_008520 DOI:10.1158/1078-0432.CCR-23-2893
3. scibot 23 May 2024
  
  in Public
  
  RRID:SCR_002285
  
  DOI: 10.1158/1078-0432.CCR-23-2893
  
  Resource: Fiji (RRID:SCR_002285)
  
  Curator: @abever99
  
  SciCrunch record: RRID:SCR_002285
  
  What is this?
  
  DOI:10.1158/1078-0432.CCR-23-2893 RRID:SCR_002285
Visit annotations in context

Tags

RRID:SCR_002285

RRID:SCR_008520

DOI:10.1158/1078-0432.CCR-23-2893

RRID:SCR_002798

Annotators

scibot

URL

aacrjournals.org/clincancerres/article/30/10/2111/745162/Xevinapant-Combined-with-Pembrolizumab-in-Patients